Terms: = Head and neck cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
18 results:
1. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
[TBL] [Abstract] [Full Text] [Related]
2. Automated Prediction of Early Recurrence in Advanced Sinonasal Squamous Cell Carcinoma With Deep Learning and Multi-parametric MRI-based Radiomics Nomogram.
Lin M; Lin N; Yu S; Sha Y; Zeng Y; Liu A; Niu Y
Acad Radiol; 2023 Oct; 30(10):2201-2211. PubMed ID: 36925335
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical Analysis of Common cancer Antigens in head and neck Squamous Cell Carcinoma.
Morishita Y; Takenouchi K; Sakashita S; Matsuura K; Hayashi R; Nakatsura T
Anticancer Res; 2022 Dec; 42(12):5751-5761. PubMed ID: 36456131
[TBL] [Abstract] [Full Text] [Related]
4. Desmoplastic Small Round Cell Tumor of the head and neck: A Clinicopathological, Immunohistochemical and Molecular Analysis of Three Cases with Literature Review.
Sun M; Shao M; Jiang X; Yin T; Wang Q; Zhao L; Liu J; Lao IW; Yu L; Wang J
Int J Surg Pathol; 2023 Aug; 31(5):742-750. PubMed ID: 36172631
[TBL] [Abstract] [Full Text] [Related]
5. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort.
Hansen CR; Bertelsen A; Zukauskaite R; Johnsen L; Bernchou U; Thwaites DI; Eriksen JG; Johansen J; Brink C
Radiother Oncol; 2020 Jun; 147():15-21. PubMed ID: 32224314
[TBL] [Abstract] [Full Text] [Related]
7. A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma.
Zauderer MG; Tsao AS; Dao T; Panageas K; Lai WV; Rimner A; Rusch VW; Adusumilli PS; Ginsberg MS; Gomez D; Rice D; Mehran R; Scheinberg DA; Krug LM
Clin Cancer Res; 2017 Dec; 23(24):7483-7489. PubMed ID: 28972039
[No Abstract] [Full Text] [Related]
8. wt1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.
Ribeiro IP; Caramelo F; Marques F; Domingues A; Mesquita M; Barroso L; Prazeres H; Julião MJ; Baptista IP; Ferreira A; Melo JB; Carreira IM
Cell Oncol (Dordr); 2016 Dec; 39(6):573-582. PubMed ID: 27491556
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological correlates of hyperparathyroidism.
Duan K; Gomez Hernandez K; Mete O
J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
[TBL] [Abstract] [Full Text] [Related]
10. Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review.
Ambroggi M; Orlandi E; Foroni RP; Cavanna L
World J Surg Oncol; 2014 Apr; 12():129. PubMed ID: 24773769
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (wt1) promotes cell proliferation: implication for cancer therapeutics.
Rather MI; Swamy S; Gopinath KS; Kumar A
J Biol Chem; 2014 Jan; 289(2):968-76. PubMed ID: 24257751
[TBL] [Abstract] [Full Text] [Related]
12. Expression of Wilms' tumor 1 (wt1) in oral squamous cell carcinoma.
Mikami T; Hada T; Chosa N; Ishisaki A; Mizuki H; Takeda Y
J Oral Pathol Med; 2013 Feb; 42(2):133-9. PubMed ID: 22672247
[TBL] [Abstract] [Full Text] [Related]
13. wt1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer.
Shirakata T; Oka Y; Nishida S; Hosen N; Tsuboi A; Oji Y; Murao A; Tanaka H; Nakatsuka S; Inohara H; Sugiyama H
Anticancer Res; 2012 Mar; 32(3):1081-5. PubMed ID: 22399636
[TBL] [Abstract] [Full Text] [Related]
14. The DNA methylome of benign and malignant parathyroid tumors.
Starker LF; Svedlund J; Udelsman R; Dralle H; Akerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2011 Sep; 50(9):735-45. PubMed ID: 21638518
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of a disease-specific quality of life questionnaire (EQOL) for potentially curable patients with carcinoma of the esophagus.
Clifton JC; Finley RJ; Gelfand G; Graham AJ; Inculet R; Malthaner R; Tan L; Lim J; Singer J; Lovato C
Dis Esophagus; 2007; 20(3):191-201. PubMed ID: 17509114
[TBL] [Abstract] [Full Text] [Related]
16. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract] [Full Text] [Related]
17. [Report of the National Oncology Research and Developement Consortium, 2003].
Tímár J
Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Nagel H; Laskawi R; Eiffert H; Schlott T
Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
[TBL] [Abstract] [Full Text] [Related]
